Open Access · CC BY 4.0
Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals
Rheumatology Advances in Practice · 06.11.2026
DOI: 10.1093/rap/rkag141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 06.11.2026. Verfasst von Akram Jalal. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jalal, A. (2026). Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals. Rheumatology Advances in Practice. https://doi.org/10.1093/rap/rkag141
Vancouver
Jalal A. Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals. Rheumatology Advances in Practice. 2026. doi:10.1093/rap/rkag141
BibTeX
@article{Jalal2026,
author = {Jalal, Akram},
title = {Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals},
journal = {Rheumatology Advances in Practice},
year = {2026},
doi = {10.1093/rap/rkag141}
}
EUVIMED